Endovascular Engineering, a Menlo Park, CA-based clot removal medtech company, raised $80 million in a Series C fundraising round led by Gilde Healthcare and Norwest with participation from Santé Ventures.
More on VCNewsDaily →
Endovascular Engineering, a Menlo Park, CA-based clot removal medtech company, raised $80 million in a Series C fundraising round led by Gilde Healthcare and Norwest with participation from Santé Ventures.
More on VCNewsDaily →
Nanordica Medical, a Tallinn-based antibiotic-free wound-care startup,...
Dentroid, a Canberra, Australia-based needle-free dental technology...
Biodimension, a Bengaluru-based human tissue models company, raised ₹80...
Firefly Bio, a Cambridge, MA-based KRAS inhibitor biotech startup, was...
Avidity Biosciences, a San Diego-based RNA-targeting therapeutics biotech,...
Uncovr, a New York and Paris-based AI for operative reports, raised $7...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.